(CDW) CDW - Overview
Stock: Hardware, Software, Services, Security, Cloud
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.50% |
| Yield on Cost 5y | 1.77% |
| Yield CAGR 5y | 10.18% |
| Payout Consistency | 100.0% |
| Payout Ratio | 26.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.8% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.91 |
| Alpha | -46.69 |
| Character TTM | |
|---|---|
| Beta | 1.111 |
| Beta Downside | 1.252 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.47% |
| CAGR/Max DD | -0.21 |
Description: CDW CDW December 19, 2025
CDW Corp (NASDAQ: CDW) is a leading IT solutions distributor operating in the United States, United Kingdom, and Canada, organized into Corporate, Small Business, and Public segments. The firm sells a broad catalog of hardware (e.g., notebooks, servers, networking gear) and software (cloud platforms, security suites, virtualization tools), and it bundles these into integrated, on-premise-or-cloud hybrid solutions covering infrastructure, digital experience, and cybersecurity.
Beyond product resale, CDW generates recurring revenue through advisory, design, implementation, managed services, and warranty contracts, serving enterprise, government, education, and healthcare customers. Its diversified service mix helps smooth earnings amid cyclical hardware demand.
Key recent metrics: FY 2023 revenue reached $20.4 billion, up ~5% YoY, with operating margin around 4.5% and free cash flow exceeding $1.2 billion. The company’s cloud-services revenue grew double-digits, reflecting broader enterprise shifts toward hybrid IT-a sector driver that the IDC estimates will sustain ~6% annual spend growth through 2027.
Strategically, CDW has leveraged acquisitions (e.g., Sirius Computer Solutions in 2021) to deepen its capabilities in managed services and vertical expertise, positioning it to capture a larger share of the $1.2 trillion U.S. technology-distribution market, where it currently holds roughly 10% market share.
For a deeper, data-driven valuation snapshot, you might explore CDW’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.43 > 1.0 |
| NWC/Revenue: 5.83% < 20% (prev 10.58%; Δ -4.75% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.22b > Net Income 1.04b |
| Net Debt (5.68b) to EBITDA (1.84b): 3.09 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (130.6m) vs 12m ago -3.19% < -2% |
| Gross Margin: 21.82% > 18% (prev 0.22%; Δ 2160 % > 0.5%) |
| Asset Turnover: 143.9% > 50% (prev 144.9%; Δ -1.02% > 0%) |
| Interest Coverage Ratio: 7.14 > 6 (EBITDA TTM 1.84b / Interest Expense TTM 228.9m) |
Altman Z'' 0.86
| A: 0.08 (Total Current Assets 8.50b - Total Current Liabilities 7.23b) / Total Assets 16.03b |
| B: -0.08 (Retained Earnings -1.31b / Total Assets 16.03b) |
| C: 0.11 (EBIT TTM 1.64b / Avg Total Assets 15.20b) |
| D: -0.12 (Book Value of Equity -1.42b / Total Liabilities 12.18b) |
| Altman-Z'' Score: 0.86 = B |
Beneish M -2.81
| DSRI: 1.21 (Receivables 6.87b/5.41b, Revenue 21.87b/20.83b) |
| GMI: 1.01 (GM 21.82% / 22.09%) |
| AQI: 1.01 (AQ_t 0.45 / AQ_t-1 0.44) |
| SGI: 1.05 (Revenue 21.87b / 20.83b) |
| TATA: -0.01 (NI 1.04b - CFO 1.22b) / TA 16.03b) |
| Beneish M-Score: -2.81 (Cap -4..+1) = A |
What is the price of CDW shares?
Over the past week, the price has changed by +12.84%, over one month by +6.16%, over three months by +1.20% and over the past year by -27.56%.
Is CDW a buy, sell or hold?
- StrongBuy: 5
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CDW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 170.4 | 19.5% |
| Analysts Target Price | 170.4 | 19.5% |
| ValueRay Target Price | 138.3 | -3% |
CDW Fundamental Data Overview February 07, 2026
P/E Forward = 13.1579
P/S = 0.8227
P/B = 6.8981
P/EG = 1.53
Revenue TTM = 21.87b USD
EBIT TTM = 1.64b USD
EBITDA TTM = 1.84b USD
Long Term Debt = 5.62b USD (from longTermDebt, last quarter)
Short Term Debt = 1.36b USD (from shortTermDebt, last quarter)
Debt = 6.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.68b USD (from netDebt column, last quarter)
Enterprise Value = 24.13b USD (18.45b + Debt 6.30b - CCE 618.7m)
Interest Coverage Ratio = 7.14 (Ebit TTM 1.64b / Interest Expense TTM 228.9m)
EV/FCF = 21.81x (Enterprise Value 24.13b / FCF TTM 1.11b)
FCF Yield = 4.58% (FCF TTM 1.11b / Enterprise Value 24.13b)
FCF Margin = 5.06% (FCF TTM 1.11b / Revenue TTM 21.87b)
Net Margin = 4.75% (Net Income TTM 1.04b / Revenue TTM 21.87b)
Gross Margin = 21.82% ((Revenue TTM 21.87b - Cost of Revenue TTM 17.10b) / Revenue TTM)
Gross Margin QoQ = 22.76% (prev 20.77%)
Tobins Q-Ratio = 1.51 (Enterprise Value 24.13b / Total Assets 16.03b)
Interest Expense / Debt = 0.93% (Interest Expense 58.5m / Debt 6.30b)
Taxrate = 24.28% (89.6m / 369.1m)
NOPAT = 1.24b (EBIT 1.64b * (1 - 24.28%))
Current Ratio = 1.18 (Total Current Assets 8.50b / Total Current Liabilities 7.23b)
Debt / Equity = 1.64 (Debt 6.30b / totalStockholderEquity, last quarter 3.85b)
Debt / EBITDA = 3.09 (Net Debt 5.68b / EBITDA 1.84b)
Debt / FCF = 5.13 (Net Debt 5.68b / FCF TTM 1.11b)
Total Stockholder Equity = 2.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.84% (Net Income 1.04b / Total Assets 16.03b)
RoE = 37.83% (Net Income TTM 1.04b / Total Stockholder Equity 2.75b)
RoCE = 19.54% (EBIT 1.64b / Capital Employed (Equity 2.75b + L.T.Debt 5.62b))
RoIC = 15.17% (NOPAT 1.24b / Invested Capital 8.16b)
WACC = 7.64% (E(18.45b)/V(24.75b) * Re(10.01%) + D(6.30b)/V(24.75b) * Rd(0.93%) * (1-Tc(0.24)))
Discount Rate = 10.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF Debug] Terminal Value 80.57% ; FCFF base≈1.20b ; Y1≈1.31b ; Y5≈1.64b
Fair Price DCF = 190.7 (EV 30.51b - Net Debt 5.68b = Equity 24.83b / Shares 130.2m; r=7.64% [WACC]; 5y FCF grow 10.02% → 2.90% )
EPS Correlation: 0.34 | EPS CAGR: 4.23% | SUE: 0.87 | # QB: 1
Revenue Correlation: -37.99 | Revenue CAGR: -2.16% | SUE: 0.62 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.27 | Chg30d=+0.070 | Revisions Net=+0 | Analysts=9
EPS current Year (2026-12-31): EPS=10.53 | Chg30d=-0.044 | Revisions Net=-2 | Growth EPS=+5.0% | Growth Revenue=+2.7%
EPS next Year (2027-12-31): EPS=11.31 | Chg30d=-0.073 | Revisions Net=-2 | Growth EPS=+7.5% | Growth Revenue=+4.2%